Arcutis Biotherapeutics Inc (ARQT) financials · rev $376.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Arcutis Biotherapeutics Inc (ARQT) rev $376.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $376.1M | $196.5M |
| Cost of Revenue | $36.7M | $19.1M |
| Gross Profit | $339.4M | $177.4M |
| Operating Income | -$12.2M | -$128.4M |
| Net Income | -$16.1M | -$140.0M |
| EPS (Diluted) | -$0.13 | -$1.16 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $433.0M | $348.9M |
| Current Assets | $411.2M | $335.8M |
| Cash & Equivalents | $42.9M | $71.3M |
| Inventory | $22.6M | $14.5M |
| PP&E | $1.04M | $1.04M |
| Total Liabilities | $243.5M | $191.3M |
| Current Liabilities | $129.8M | $81.0M |
| Short-term Debt | $1.00M | N/A |
| Long-term Debt | $108.0M | $107.2M |
| Total Debt | $109.0M† | $107.2M† |
| Shareholders' Equity | $189.5M | $157.5M |
| Retained Earnings | -$1.14B | -$1.12B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$5.63M | -$112.2M |
| CapEx | $686.0K | $143.0K |
| Investing Cash Flow | -$30.3M | $28.8M |
| Financing Cash Flow | $6.97M | $66.2M |
| Net Change in Cash | -$28.7M | -$17.4M |
| Free Cash Flow | -$6.31M | -$112.3M |
FAQ
What is ARQT P/E and revenue?
Arcutis Biotherapeutics Inc (ARQT) rev $376.1M.
What is ARQT revenue?
Arcutis Biotherapeutics Inc last cached revenue is $376.1M (FY2025).
Is ARQT profitable?
Arcutis Biotherapeutics Inc last cached net income is -$16.1M (FY2025).
What are ARQT total assets?
Arcutis Biotherapeutics Inc last cached total assets are $433.0M (FY2025).
What is ARQT free cash flow?
Arcutis Biotherapeutics Inc last cached free cash flow is -$6.31M (FY2025).
Not investment advice. Cached statements, not a live tape.